Protein-energy Enriched Milk for Infants With Bronchiolitis
PEMIB
1 other identifier
interventional
44
1 country
1
Brief Summary
The aim of this study is to investigate if a standardized nutritional intervention with a protein and energy enriched milk could help overcome the catabolic state in children hospitalized with a bronchiolitis and thus creating a better nutritional state during hospitalization and at outpatient follow-up. The investigators also want to assess the clinical repercussion on the number of hospitalization days, the duration of oxygen support and the quality of life at ouptatient follow-up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2014
CompletedFirst Submitted
Initial submission to the registry
December 5, 2014
CompletedFirst Posted
Study publicly available on registry
December 12, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2016
CompletedJune 16, 2015
June 1, 2015
1.2 years
December 5, 2014
June 15, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evolution of nutritional status during hospitalization
The change in followong parameters will be assessed: * Change in weight for age z-score * Change in mid upper arm circumference z-score * Change in triceps skin fold (mm)
Hospital stay (mean 5 days)
Secondary Outcomes (1)
Evolution of nutritional status at outpatient follow-up
1 week after discharge
Other Outcomes (6)
The Quality of life at outpatient follow-up
1 week after discharge
Duration of hospital stay
Hospital stay (mean 5 days)
Time of oxygen support
Hospital stay (mean 5 days)
- +3 more other outcomes
Study Arms (2)
Intervention group
EXPERIMENTALChildren in the intervention group will receive a protein-energy enriched milk (Infatrini®, or in the case of children on a partial or fully hydrolized milk Infatrini Peptisorb®). The volume of milk offered will be the same quantity as they usually drink at home (within the limits of 120-170 ml/kg/day). The intervention will be carried out during the first 7 days of hospitalisation, or until the day of discharge (if hospitalized for less than 7 days).
Control group
NO INTERVENTIONChildren in the control group will receive their regular milk. The volume of milk offered will be the same quantity as they usually drink at home (within the limits of 120-170 ml/kg/day).
Interventions
Eligibility Criteria
You may qualify if:
- All children hospitalized at the paediatric wards of UZ Brussel with the diagnosis of moderate to severe bronchiolitis
- Bronchiolitis will be defined as a constellation of clinical symptoms and signs that typically begin with rhinitis and cough, and may progress to tachypnea, wheezing, rales, use of accessory muscles and/or nasal flaring
You may not qualify if:
- Children admitted to the paediatric intensive care unit
- Children in whom it is unsafe to place a nasogastric tube (e.g. severe mucositis, platelet count \<50.000/µl)
- Children unwilling or unable to participate
- Children that are breast fed
- Children over the age of 12 months
- Children with an underlying malabsorption disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UZ Brussel
Jette, 1090, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yvan Vandenplas, MD, PhD
UZBrussel
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr.
Study Record Dates
First Submitted
December 5, 2014
First Posted
December 12, 2014
Study Start
December 1, 2014
Primary Completion
March 1, 2016
Study Completion
April 1, 2016
Last Updated
June 16, 2015
Record last verified: 2015-06